CION Ameerpet
Limb-Sparing Surgery · Chemotherapy · NABH Accredited
Bone Cancer Treatment in Hyderabad — Expert Oncology Care Across 7 Locations
A bone cancer diagnosis raises immediate fears — most of all, the fear of losing a limb. Today, the vast majority of patients with bone tumours in the arms or legs can be treated with limb-sparing surgery — removing the cancer while preserving the limb. At CION Cancer Clinics, our surgical and medical oncology team delivers expert bone cancer care across 7 Hyderabad locations, backed by NABH accreditation and NCCN protocol-driven treatment planning.
- Limb-Sparing in 85–90% of eligible patients — amputation is the exception, not the rule
- AIIMS-Trained Surgical Oncologist — Dr. Muralidhar Muddusetty leads complex bone sarcoma resections
- NCCN Protocol Adherence — multidisciplinary tumour board reviews every case before treatment begins
- 7 Hyderabad Locations — Kukatpally, Kompally, Ameerpet, Tolichowki, MasabTank, L.B. Nagar, Banjara Hills · EMI & insurance accepted
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Did You Know? In the 1970s, more than 80% of bone cancer patients required amputation. Today, advances in chemotherapy and surgical techniques mean that limb-sparing surgery successfully preserves the limb in approximately 85 to 90% of eligible patients. The cancer is removed, the gap in the bone is filled with a metallic implant or bone graft, and with rehabilitation most patients regain near-normal function.
Two Very Different Situations — Primary and Secondary Bone Cancer
When people hear "bone cancer," they often picture one disease. In practice, there are two very different situations — and they are managed completely differently.
Starts in the bone
Primary Bone Cancer
Cancer that starts in the bone itself. This is relatively rare. The main types are osteosarcoma, Ewing sarcoma, and chondrosarcoma. These require specialist bone tumour surgery, often combined with chemotherapy.
Spread from elsewhere
Secondary Bone Cancer (Bone Metastases)
Cancer that started elsewhere — most commonly the breast, prostate, lung, or kidney — and has spread to the bones. Far more common than primary bone cancer. Treatment focuses on controlling pain, preventing fracture, and managing the underlying cancer.
Understanding which situation applies to you is the first step in understanding what treatment is appropriate and what to expect.
Types of Primary Bone Cancer We Treat
Each subtype responds to treatment differently. Identifying the exact type — through biopsy and pathology — is the foundation of every effective treatment plan.
Ages 10–25 · Most common
Osteosarcoma
The most common primary bone cancer. Develops in bone-forming cells and mainly affects teenagers and young adults — a period of rapid bone growth. Most common around the knee and upper arm. Aggressive but responds well to chemotherapy. Treatment begins with chemotherapy to shrink the tumour, then limb-sparing surgery. 5-year survival of 60 to 75% for cancer that has not spread.
Ages 5–20
Ewing Sarcoma
Most often appears in people aged 5 to 20. Common locations are the pelvis, thigh, upper arm, and ribs. Like osteosarcoma, treated with chemotherapy before surgery. Highly sensitive to radiation — so it can sometimes be controlled with radiation instead of surgery when the tumour is in a location that is hard to operate on.
Ages 40–70
Chondrosarcoma
Grows from cartilage cells and is most common in adults aged 40 to 70. There is a critical difference every patient needs to know: chondrosarcoma does not respond to chemotherapy or radiation. Surgery — complete removal with clear margins — is the primary and usually the only effective treatment. This is why the quality of the first operation matters enormously.
Less common
Chordoma, Giant Cell & Others
Chordoma — a slow-growing cancer of the spine or skull base; treated with surgery and specialist radiation. Giant cell tumour of bone — often treated with surgery and, in some cases, a medicine that helps control tumour activity. Multiple myeloma — a blood cancer affecting the bone marrow; treated with systemic medicines rather than bone surgery.
Who Is at Risk of Bone Cancer?
Primary Bone Cancer
- Age — osteosarcoma predominantly affects 10 to 25 year olds; chondrosarcoma is more common in adults over 40
- Previous radiation treatment — radiation given for another cancer can, in rare cases, increase bone sarcoma risk in the treated area years later
- Paget's disease of the bone — a condition causing abnormal bone rebuilding, mainly in people over 60; carries a small increased risk
- Inherited genetic conditions — Li-Fraumeni syndrome, hereditary retinoblastoma, and neurofibromatosis type 1 are rare inherited conditions that increase bone cancer risk
- Rapid growth in adolescence — thought to create conditions where cell division errors in bone are more likely, explaining osteosarcoma's peak in teenagers
Secondary Bone Cancer
Any patient with advanced breast, prostate, lung, kidney, or thyroid cancer is at risk of bone spread. The spine, pelvis, ribs, and upper ends of the arm and thigh bones are the most common affected sites.
Warning Signs of Bone Cancer
- Persistent bone pain — particularly pain present at rest or during the night, not caused by injury; distinguishes it from sporting injuries or growing pains in teenagers
- Swelling or a lump around a bone or joint — may develop gradually over weeks
- Bone fracture from a minor injury — a break from a small fall or trip may mean the bone has been weakened by a tumour
- Restricted movement in a nearby joint — a tumour near the knee, hip, or shoulder can limit how freely it moves
- Unexplained tiredness and weight loss
In teenagers, bone pain around the knee or shoulder is easy to put down to sport or growing pains. Pain that is consistently present at night, not linked to exercise, or accompanied by swelling should always be checked. Early diagnosis significantly improves the chances of limb-sparing surgery.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a Second Opinion Before Surgery
If amputation has been recommended, or surgery proposed without chemotherapy first — bring your MRI and biopsy to CION for a tumour-board review. We walk this journey with you.
How Is Bone Cancer Diagnosed at CION?
CION's diagnostic pathway combines imaging and biopsy under one tumour board — so the right diagnosis, type, and stage are confirmed before any treatment decision is made.
Imaging
- X-ray — the first investigation; shows abnormal bone structure or areas of destruction
- MRI — essential for surgery planning; shows the tumour's full extent within the bone, proximity to blood vessels and nerves, and whether limb-sparing surgery is feasible
- CT Scan (chest) — checks whether the cancer has spread to the lungs
- Bone scan — checks whether cancer has spread to other bones
- PET-CT — for staging and assessing how well the tumour has responded to pre-surgery chemotherapy
Biopsy
A biopsy confirms the diagnosis and identifies the exact type of cancer. For bone tumours, biopsy planning is critical — the biopsy site must be placed so it can be completely removed as part of the surgery that follows. A poorly planned biopsy that contaminates surrounding tissue can prevent limb-sparing surgery. At CION, biopsy planning is coordinated with the surgical oncology team before any sample is taken.
Bone Cancer Staging and Survival
Primary bone cancer staging uses the AJCC system, which considers tumour size, grade (how aggressive the cells look), and whether the cancer has spread. Stage and response to pre-surgery chemotherapy are the two most important survival predictors.
| Stage | Tumour Status | Spread | 5-Year Survival* | Treatment |
|---|---|---|---|---|
| Stage IA | Low-grade, ≤8 cm | Confined to bone | 85–95% | Surgery; chemo not needed for chondrosarcoma |
| Stage IB | Low-grade, >8 cm | Same bone, no distant spread | 70–85% | Surgery with wide excision & bone replacement |
| Stage IIA | High-grade, ≤8 cm | Confined to bone | 60–75% | Chemo → limb-sparing surgery → chemo |
| Stage IIB | High-grade, >8 cm | Confined to bone | 50–65% | Chemo → surgery → chemo; radiation for Ewing |
| Stage III | Any grade, skip lesion | Two areas in same bone | 40–55% | Chemo → surgery → chemo |
| Stage IV | Any grade with spread | Lung or other bones | 20–30% | Chemo + surgery for metastases if removable; radiation |
*Survival estimates are for osteosarcoma and Ewing sarcoma at specialist centres. Low-grade chondrosarcoma has better stage-specific survival given its slower growth. Every case is reviewed by CION's multidisciplinary tumour board before treatment begins.
Chemotherapy First, Surgery Second — Why This Order Matters
For patients with osteosarcoma and Ewing sarcoma, treatment does not begin with an operation. The standard approach starts with a course of chemotherapy — given over 9 to 12 weeks — before surgery. This matters for three important reasons:
- It shrinks the tumour first — making surgery technically easier and significantly increasing the proportion of patients for whom limb-sparing surgery is possible
- It destroys cancer cells already in the bloodstream — even when these cannot yet be detected on any scan
- It predicts long-term survival — when the removed tumour is examined after surgery, the proportion of cancer cells killed by chemotherapy is assessed. A high kill rate predicts better long-term outcomes; a poorer response may need adjusted treatment after surgery
After surgery, chemotherapy continues for several more months. The full chemotherapy course — before and after surgery — typically spans around 9 to 12 months total. CION's medical oncology team delivers this in a day-care setting with monitoring throughout.
One important distinction: chondrosarcoma does not respond to chemotherapy. Patients with chondrosarcoma go straight to surgery — which is why getting the right diagnosis before treatment starts is essential.
Can Bone Cancer Be Treated Without Amputation?
For most patients, yes. In the 1970s, amputation was the standard for most bone cancers of the arms and legs. Today, limb-sparing surgery preserves the limb in approximately 85 to 90% of eligible patients. The cancerous bone is removed with a clear margin, and the gap is reconstructed using one of the following:
Custom Metallic Implant
A custom-designed metal replacement fixed to the remaining bone — the most common approach for adults. Surrounding muscles and tendons are reattached; it functions like a joint replacement.
Patient's Own Bone (Autograft)
Bone taken from another part of the patient's body — typically the smaller lower leg bone — to bridge the gap. The body eventually grows new bone into the graft, creating durable biological reconstruction.
Donor Bone (Allograft)
Bone shaped from a bone bank to fit the defect. A reconstruction option where autograft is not feasible or where structural support is the priority.
For children and teenagers who are still growing, expandable metallic implants are used. These can be lengthened as the child grows — using a non-surgical procedure — matching the healthy leg's length and avoiding multiple repeat operations.
Amputation remains necessary in a minority of cases — when the tumour directly involves the main blood vessels or nerve bundles that cannot be safely separated from the tumour. CION's tumour board reviews every case before finalising a surgical plan.
Rehabilitation After Limb-Sparing Surgery
Surgery is the start of recovery, not the end. Physiotherapy begins within days of the operation and continues for months. Restoring strength, flexibility, and joint function requires dedicated rehabilitation — which CION plans from the time of diagnosis so recovery starts alongside treatment, not after it.
Radiation Therapy for Ewing Sarcoma and Inoperable Bone Tumours
Radiation plays a more significant role in bone cancer than most patients expect — particularly for Ewing sarcoma, which is highly sensitive to radiation. Radiation is used in two situations for Ewing sarcoma:
- As the primary local treatment when surgery would cause unacceptable damage — for example, tumours in the pelvis or spine; radiation combined with chemotherapy achieves local control without an operation
- After surgery when the margins are not clear — when cancer cells were found at the edge of the removed specimen; radiation reduces the risk of the cancer coming back
For other inoperable bone tumours, radiation provides meaningful local control and pain relief. CION delivers radiation using IMRT — a precision technique that shapes the beam to the tumour and protects adjacent nerves, blood vessels, and healthy bone.
Did You Know? For children and teenagers with bone cancer, specially designed expandable metallic implants can grow with the child. As the healthy leg grows, the implant in the treated leg is lengthened to match — using a non-surgical procedure — so the child's legs stay the same length. This avoids multiple repeat operations and allows children to grow up with full use of both limbs.
When Another Cancer Has Spread to the Bones
Secondary bone cancer — when cancer from the breast, prostate, lung, kidneys, or thyroid spreads to the bones — is far more common than primary bone cancer. The goals of treatment are: reducing bone pain, lowering the risk of fracture, and slowing further bone damage.
Bone-Strengthening Infusions
Regular intravenous infusions of bone-strengthening medicines reduce the breakdown of bone by cancer deposits — lowering fracture risk and reducing bone pain over time. Given as a short outpatient infusion, usually once monthly, and well tolerated.
Targeted Radiation for Painful Lesions
One of the most effective pain-relief treatments in oncology. A short course — sometimes just 1 to 5 sessions — reliably reduces or eliminates bone pain in the treated area. It also reduces fracture risk in bones that have been weakened by a deposit.
Surgical Stabilisation
When a bone has been significantly weakened by a deposit — particularly the thigh bone, upper arm, or spine — a metal rod or plate can be inserted to stabilise the bone and prevent fracture. When a fracture has already occurred, surgery repairs the fracture and stabilises the bone.
Every Case Reviewed by a Team Before Treatment Begins
Bone cancer management requires surgical oncology, medical oncology, radiation oncology, pathology, and radiology to work together from the start. At CION, every bone cancer case is reviewed by our multidisciplinary team before treatment begins:
- Biopsy site planning — coordinated to ensure the biopsy does not compromise subsequent limb-sparing surgery
- Chemotherapy before surgery — timing, regimen, and monitoring for osteosarcoma and Ewing sarcoma
- Limb-sparing feasibility — MRI reviewed to confirm whether clear margins are achievable without sacrificing major blood vessels or nerves
- Reconstruction planning — metallic implant, bone graft, or expandable prosthetic for children
- Chondrosarcoma identified correctly — surgery-only pathway confirmed; chemotherapy not started
- Ewing sarcoma local treatment — surgery vs radiation vs combined, based on location and resectability
- Bone metastases plan — bone-strengthening infusions, palliative radiation, and surgical stabilisation coordinated together
- Rehabilitation planning from day one — physiotherapy targets set before limb-sparing surgery
- NCCN and ESMO Protocol Adherence across all bone cancer types
- Digital coordination across all 7 Hyderabad locations
Why Patients Choose CION for Bone Cancer Treatment in Hyderabad
Eleven reasons our patients pick CION — across volume, AIIMS-trained surgical expertise, NCCN protocols, and supportive care.
1,000+ cancer cases
7 locations across Hyderabad
5-Star NABH Accredited
NCCN Protocol Adherence
AIIMS-trained surgical oncologist
Limb-sparing in 85–90% of eligible patients
Multidisciplinary tumour board review
Dedicated Second Opinion service
EMI & insurance accepted
4.8 / 5 Google rating
35+ centres across Telangana & AP
Bone Cancer Treatment Cost in Hyderabad
Costs vary widely depending on whether the cancer is primary or secondary, the type and stage, and the extent of surgery and reconstruction. The figures below are indicative — a personalised cost estimate is provided following your initial oncology consultation at CION.
| Treatment | Approx. Cost (INR) | Notes |
|---|---|---|
| Limb-Sparing Surgery (tumour + metallic implant) | ₹3,00,000 – ₹9,00,000 | Varies by bone, implant type, and complexity |
| Expandable Prosthesis for Children | ₹5,00,000 – ₹12,00,000 | Custom growing implant; additional for adjustments |
| Amputation + Prosthetic Limb | ₹2,50,000 – ₹7,00,000 | For cases where limb sparing is not possible |
| Chemotherapy Before Surgery (9–12 weeks) | ₹1,50,000 – ₹4,00,000 | For osteosarcoma and Ewing sarcoma |
| Chemotherapy After Surgery (per cycle) | ₹25,000 – ₹80,000 | Continues 6–9 months post-surgery |
| Radiation Therapy — IMRT (full course) | ₹1,20,000 – ₹2,50,000 | For Ewing sarcoma or inoperable tumours |
| Bone-Strengthening Infusion (per dose) | ₹5,000 – ₹20,000 | Monthly for bone metastases |
| Full Multi-modal Treatment | ₹4,00,000 – ₹20,00,000+ | Depending on type, reconstruction, and chemo duration |
Financial Support Options
- EMI Facility — flexible instalment-based payment options available for all patients
- Private Health Insurance — CION works with all major TPAs for cashless hospitalisation
- Government Schemes — Aarogyasri, CGHS, ECHS & ESI cashless support for eligible patients (subject to scheme coverage for the specific procedure)
Take The First Step
Consult a Bone Cancer Specialist Today
Same-week appointments across 7 Hyderabad locations. Bring your imaging — we'll tell you honestly what your options are.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Bone Cancer Treatment — Frequently Asked Questions
What are the symptoms of bone cancer?
The most telling symptom is persistent bone pain that is present at rest or at night, not caused by an injury and not relieved by ordinary pain medicines. Swelling or a lump around a bone or joint, a bone fracture from a minor bump or fall (indicating the bone has been weakened), restricted movement in a nearby joint, and unexplained tiredness or weight loss are other warning signs. In teenagers, pain around the knee or shoulder that consistently appears at night or is not related to sport should always be evaluated — it should not be written off as growing pains.
Is bone cancer curable?
Yes — primary bone cancer is curable, particularly when found before it has spread. Osteosarcoma and Ewing sarcoma confined to the bone have 5-year survival rates of 60 to 75% with modern chemotherapy and surgery. Low-grade chondrosarcoma treated with complete surgical removal has survival rates of 85 to 95%. The two most important factors are: how early the cancer is found, and whether the first surgery completely removes it with clear margins around the entire tumour.
What causes bone cancer?
For most people, no clear cause is identified. Known risk factors for primary bone cancer include: rapid bone growth during adolescence (linked to osteosarcoma); previous radiation treatment to the area; Paget's disease of the bone in older adults; and rare inherited genetic conditions such as Li-Fraumeni syndrome. Ewing sarcoma has no well-established environmental cause. Chondrosarcoma risk increases with age. Secondary bone cancer is caused by spread from another cancer — most commonly breast, prostate, lung, kidney, or thyroid.
Can bone cancer be treated without amputation?
Yes — in the great majority of patients. Limb-sparing surgery now preserves the limb in approximately 85 to 90% of eligible patients. The tumour and a margin of surrounding healthy tissue are removed, and the bone gap is reconstructed with a metallic implant or bone graft. For children still growing, expandable implants that lengthen as the child grows are available. Amputation is only needed when the tumour directly involves the main blood vessels or nerves supplying the limb, making safe removal with clear margins impossible.
What is osteosarcoma?
Osteosarcoma is the most common primary bone cancer, mainly affecting teenagers and young adults aged 10 to 25. It develops in the cells that form bone and most commonly appears around the knee or in the upper arm near the shoulder. It grows quickly, but it responds well to chemotherapy — the standard treatment starts with a chemotherapy course to shrink the tumour, followed by limb-sparing surgery, then further chemotherapy after the operation. With this approach, most patients with osteosarcoma that has not spread have a 60 to 75% chance of long-term cure.
What is the difference between primary and secondary bone cancer?
Primary bone cancer starts in the bone — examples are osteosarcoma, Ewing sarcoma, and chondrosarcoma. It is rare. Secondary bone cancer (bone metastases) means cancer from another part of the body — most commonly breast, prostate, or lung — has spread to the bones. This is far more common. The two are managed differently: primary bone cancer is treated with surgery and chemotherapy; secondary bone cancer is treated with systemic medicines for the original cancer, monthly bone-strengthening infusions, and radiation to painful bone deposits.
What is the survival rate for bone cancer?
Survival varies significantly by type and stage. For osteosarcoma and Ewing sarcoma confined to the bone, the 5-year survival rate is 60 to 75% with modern treatment. Stage IV (spread to lungs) has a 5-year survival of approximately 20 to 30%, though some patients are cured when all lung deposits can be removed. Low-grade chondrosarcoma with complete surgery has survival of 85 to 95%. The most important factor across all types is complete surgical removal — which is why specialist surgical expertise and biopsy planning matter enormously.
What is limb-sparing surgery?
Limb-sparing surgery removes a bone tumour while keeping the limb. The cancerous section of bone is taken out with a clear margin of healthy tissue around it. The resulting gap is reconstructed — usually with a custom-designed metallic implant, bone from another part of the patient's body, or donor bone. The surrounding muscles and tendons are reattached to the implant. With physiotherapy, most patients regain near-normal function. For children still growing, expandable implants that lengthen as the child grows are used to keep the legs the same length.
What is the cost of bone cancer treatment in Hyderabad?
Limb-sparing surgery with a metallic implant costs ₹3,00,000 to ₹9,00,000. Expandable prosthetics for children cost ₹5,00,000 to ₹12,00,000. Chemotherapy before surgery costs ₹1,50,000 to ₹4,00,000. Post-surgery chemotherapy cycles cost ₹25,000 to ₹80,000 per cycle over 6 to 9 months. IMRT radiation costs ₹1,20,000 to ₹2,50,000. Monthly bone-strengthening infusions cost ₹5,000 to ₹20,000 per dose. CION provides a personalised estimate after your consultation. EMI options are available.
Can I get a second opinion for bone cancer?
Absolutely — and for bone cancer, a second opinion is particularly valuable if: amputation has been recommended without assessing whether limb-sparing is feasible; surgery is being recommended for osteosarcoma or Ewing sarcoma without chemotherapy first (chemotherapy before surgery is the established standard); or chondrosarcoma has been diagnosed and chemotherapy offered (chondrosarcoma does not respond to chemotherapy — surgery is the correct treatment). CION offers a dedicated Second Opinion service reviewing your MRI, biopsy results, and current recommendation.